The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty

Eric KeuffelCTI Clinical Trial and Consulting Services, Inc., Covington, KY, USA; ;Health Finance & Access Initiative, Bryn Mawr, PACorrespondence[email protected]

http://orcid.org/0000-0001-5350-2272

Peter A. McCulloughBaylor University Medical Center, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, and Baylor Heart and Vascular Institute, Dallas, TX, USA; ;Texas A&M Health Science Center, College of Medicine, Dallas, TX, USA;

Thomas M. TodoranMedical University of South Carolina, Charleston, SC, USA;

Emmanouil S. BrilakisMinneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA;

Swetha R. PalliCTI Clinical Trial and Consulting Services, Inc., Covington, KY, USA;

Michael P. RyanCTI Clinical Trial and Consulting Services, Inc., Covington, KY, USA;

Candace GunnarssonCTI Clinical Trial and Consulting Services, Inc., Covington, KY, USA;

show all

The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty

Supplemental Material

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date